Clinical and functional status over the first three months of treatment: Results from the Schizophrenia Outpatient Health Outcomes (SOHO) study

被引：0
|
作者：
Edgell, ET [1 ]
Haro, JM [1 ]
Frewer, P [1 ]
Wright, P [1 ]
机构：
[1] Eli Lilly & Co Ltd, Lilly Res Ctr, Surrey, England
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80456-5
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：282 / 282
页数：1
相关论文
共 50 条
  • [41] Olanzapine, risperidone or quetiapine treatment initiation: 12-month schizophrenia outpatient health outcomes (SOHO) study results
    Novick, D
    Haro, JM
    Belger, M
    Tzivelekis, S
    Alonso, J
    Gasquet, I
    Kristensen, H
    Jones, PB
    Knapp, M
    Lepine, JP
    Mavreas, V
    Murray, D
    Naber, D
    Pancheri, P
    Slooff, CJ
    Teixeira, JM
    EUROPEAN PSYCHIATRY, 2004, 19 : 172S - 173S
  • [42] The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Hong, Jihyung
    Windmeijer, Frank
    Novick, Diego
    Maria Haro, Josep
    Brown, Jacqueline
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (05) : 835 - 841
  • [43] Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study
    Haro, Josep Maria
    Novick, Diego
    Bertsch, Jordan
    Karagianis, Jamie
    Dossenbach, Martin
    Jones, Peter B.
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 199 (03) : 194 - 201
  • [44] Patient characteristics and clinical status of patients prescribed monotherapy or combination antipsychotic treatment: Baseline results from the intercontinental outpatient health outcomes study (IC SOHO)
    Levitt, L
    Becker, S
    Dossenbach, M
    Busselen, M
    Png, CH
    Lee, MH
    Kim, CY
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S318 - S318
  • [45] Factors associated with remission in schizophrenia: 36-months results from the French cohort of the schizophrenia outpatients health outcomes (SOHO) study
    Gasquet, Isabelle
    Avoinet, Sandra
    Chartier, Florence
    Tcherny-Lessenot, Stephanie
    Lepine, Jean-Pierre
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S159 - S160
  • [46] The treatment of schizophrenia across Europe: Between country baseline differences in the schizophrenia outpatient health outcomes (SOHO) study
    Edgell, ET
    Haro, JM
    Frewer, P
    Wright, P
    Novick, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S317 - S317
  • [47] Clinical status course and quality of life: 24-month results from the European schizophrenia outpatients health outcomes (SOHO) study
    Haro, JM
    Novick, D
    Belger, M
    Ratcliffe, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S496 - S496
  • [48] RISK FACTORS FOR SUICIDE IN THE OBSERVATIONAL SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES (SOHO) STUDY
    Novick, D.
    Brugnoli, R.
    Haro, J. M.
    Rossi, A.
    Bortolomasi, M.
    Frediani, S.
    Borgherini, G.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [49] The European Schizophrenia Outpatient Health Outcomes (SOHO) study: Rationale, methods and recruitment
    Haro, JM
    Edgell, ET
    Jones, PB
    Alonso, J
    Gavart, S
    Gregor, KJ
    Wright, P
    Knapp, M
    ACTA PSYCHIATRICA SCANDINAVICA, 2003, 107 (03) : 222 - 232
  • [50] The treatment of schizophrenia across Europe: Between-country baseline differences in the schizophrenia outpatient health outcomes (SOHO) study
    Haro, JM
    Edgell, ET
    Frewer, P
    Novick, D
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 265 - 265
12345